Clicky

Vivani Medical, Inc.(VANI) News

Date Title
Aug 5 Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 Phase 1 Clinical Study of NPM-115
Aug 5 EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data
Jul 16 3 Penny Stocks With Market Caps Over $30M To Consider
Jun 30 Vivani Medical Insiders Added US$5.29m Of Stock To Their Holdings
May 13 Vivani Medical: Q1 Earnings Snapshot
May 13 Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results
Sep 27 Vivani Medical obtains Australian approval to begin GLP-1 implant trial
Sep 26 Vivani Medical to Test Implant in Obese and Overweight Patients
Sep 26 Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
Sep 26 EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
Sep 24 Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
Sep 23 Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
Jun 13 Vivani Medical Receives FDA Clearance for Trial of Type-2 Diabetes Mini-Implant
Jun 13 EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED)
Jun 13 Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
May 28 EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
May 28 Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant
May 13 Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
May 9 Vivani Medical to Present at TIDES Conference 2024
Mar 27 Vivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial Results